Regulation of cellular metabolism and hypoxia by p53

Cold Spring Harbor Perspectives in Medicine

Volumn 6, Issue 7, 2016, Pages

  Humpton, Timothy J ^a   Vousden, Karen H ^a  

^a BEATSON INSTITUTE FOR CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53; REACTIVE OXYGEN METABOLITE;

AMINO ACID METABOLISM; ARTICLE; AUTOPHAGY; CARBOHYDRATE METABOLISM; CELL KILLING; CELL METABOLISM; CELL PROLIFERATION; CELL SURVIVAL; HYPOXIA; LIPID METABOLISM; NONHUMAN; NUTRIENT AVAILABILITY; OXIDATION REDUCTION REACTION; ANIMAL; CELL HYPOXIA; HUMAN; METABOLIC SYNDROME X; METABOLISM; PHYSIOLOGICAL STRESS; PHYSIOLOGY;

ANIMALS; CARBOHYDRATE METABOLISM; CELL HYPOXIA; HUMANS; LIPID METABOLISM; METABOLIC SYNDROME; OXIDATION-REDUCTION; STRESS, PHYSIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84977558184     PISSN: None     EISSN: 21571422     Source Type: Journal    
DOI: 10.1101/cshperspect.a026146     Document Type: Article

References (148)

1. Alarcón R, Koumenis C, Geyer RK, Maki CG, Giaccia AJ. 1999. Hypoxia induces p53 accumulation through MDM2 down-regulation and inhibition of E6-mediated degradation. Cancer Res 59: 6046-6051.
2. Allocati N, Di Ilio C, De Laurenzi V. 2012. p63/p73 in the control of cell cycle and cell death. Exp Cell Res 318: 1285-1290.
3. Ambs S, Ogunfusika MO, Merriam WG, Bennett WP, Billiar TR, Harris CC. 1998. Up-regulation of inducible nitric oxide synthase expression in cancer-prone p53 knockout mice. Proc Natl Acad Sci 95: 8823-8828.
4. An WG, Kanekal M, Simon MC, Maltepe E, Blagosklonny MV, Neckers LM. 1998. Stabilization of wild-type p53 by hypoxia-inducible factor 1a. Nature 392: 405-408.
5. Armata HL, Golebiowski D, Jung DY, Ko HJ, Kim JK, Sluss HK. 2010. Requirement of the ATM/p53 tumor suppressor pathway for glucose homeostasis. Mol Cell Biol 30: 5787-5794.
6. Assaily W, Rubinger DA, Wheaton K, Lin Y, Ma W, Xuan W, Brown-Endres L, Tsuchihara K, Mak TW, Benchimol S. 2011. ROS-mediated p53 induction of Lpin1 regulates fatty acid oxidation in response to nutritional stress. Mol Cell 44: 491-501.
7. Bellot G, Garcia-Medina R, Gounon P, Chiche J, Roux D, Pouysségur J, Mazure NM. 2009. Hypoxia-induced autophagy is mediated through hypoxia-inducible factor induction of BNIP3 and BNIP3L via their BH3 domains. Mol Cell Biol 29: 2570-2581.
8. Bensaad K, Tsuruta A, Selak MA, Vidal MNC, Nakano K, Bartrons R, Gottlieb E, Vousden KH. 2006. TIGAR, a p53-inducible regulator of glycolysis and apoptosis. Cell 126: 107-120.
9. Boidot R, Végran F, Meulle A, Le Breton A, Dessy C, Son-veaux P, Lizard-Nacol S, Feron O. 2012. Regulation of monocarboxylate transporter MCT1 expression by p53 mediates inward and outward lactate fluxes in tumors. Cancer Res 72: 939-948.
10. Bois-Joyeux B, Chanez M, Peret J. 1987. Changes in rat hepatic fructose 2,6-bisphosphate and 6-phospho-fructo-2-kinase/fructose 2,6-bisphosphatase activity during three days of consumption of a high protein diet or starvation. Diabete Metab 13: 543-548.
11. Bourdon A, Minai L, Serre V, Jais JP, Sarzi E, Aubert S, Chrétien D, de Lonlay P, Paquis-Flucklinger V, Arakawa H, et al. 2007. Mutation of RRM2B, encoding p53-controlled ribonucleotide reductase (p53R2), causes severe mitochondrial DNA depletion. Nat Genet 39: 776-780.
12. Bowtell JL, Bruce M. 2002. Glutamine: An anaplerotic precursor. Nutrition 18: 222-224.
13. Budanov AV. 2011. Stress-responsive sestrins link p53 with redox regulation and mammalian target of rapamycin signaling. Antioxid Redox Signal 15: 1679-1690.
14. Burgdorf KS, Grarup N, Justesen JM, Harder MN, Witte DR, Jørgensen T, Sandbæk A, Lauritzen T, Madsbad S, Hansen T, et al. 2011. Studies of the association of Arg72Pro of tumor suppressor protein p53 with type 2 diabetes in a combined analysis of 55,521 Europeans. PLoS ONE 6: 4-9.
15. Cano CE, Gommeaux J, Pietri S, Culcasi M, Garcia S, Seux M, Barelier S, Vasseur S, Spoto RP, Pébusque MJ, et al. 2009. Tumor protein 53-induced nuclear protein 1 is a major mediator of p53 antioxidant function. Cancer Res 69: 219-226.
16. Chen W, Sun Z, Wang XJ, Jiang T, Huang Z, Fang D, Zhang DD. 2009. Direct interaction between Nrf2 and p21Cip1/WAF1 upregulates the Nrf2-mediated anti-oxidant response. Mol Cell 34: 663-673.
17. Chen W, Jiang T, Wang H, Tao S, Lau A, Fang D, Zhang DD. 2012. Does Nrf2 contribute to p53-mediated control of cell survival and death? Antioxid Redox Signal 17: 1670-1675.
18. Cheung EC, Ludwig RL, Vousden KH. 2012. Mitochondrial localization of TIGAR under hypoxia stimulates HK2 and lowers ROS and cell death. Proc Natl Acad Sci 109: 20491-20496.
19. Circu ML, Aw TY. 2010. Reactive oxygen species, cellular redox systems, and apoptosis. Free Radic Biol Med 48: 749-762.
20. Claus TH, Nyfeler F, Muenkel HA, Burns MG, Pilkis SJ. 1984. Changes in ructose-2,6-bisphosphate levels after glucose loading of starved rats. Biochem Biophys Res Com-mun 122: 529-534.
21. Clemens MJ. 2001. Initiation factor eIF2a phosphorylation in stress responses and apoptosis. Prog Mol Subcell Biol 27: 57-89.
22. Contractor T, Harris CR. 2012. p53 negatively regulates transcription of the pyruvate dehydrogenase kinase Pdk2. Cancer Res 72: 560-567.
23. D’Autréaux B, Toledano MB. 2007. ROS as signalling molecules: Mechanisms that generate specificity in ROS homeostasis. Nat Rev Mol Cell Biol 8: 813-824.
24. Derdak Z, Lang CH, Villegas KA, Tong M, Mark NM, De La Monte SM, Wands JR. 2011. Activation of p53 enhances apoptosis and insulin resistance in a rat model of alcoholic liver disease. J Hepatol 54: 164-172.
25. Dieuaide M, Brouquisse R, Pradet A, Raymond P. 1992. Increased fatty acid b-oxidation after glucose starvation in maize root tips. Plant Physiol 99: 595-600.
26. Droge W. 2002. Free radicals in the physiological control of cell function. Physiol Rev 82: 47-95.
27. Faraonio R, Vergara P, Di Marzo D, Pierantoni MG, Napolitano M, Russo T, Cimino F. 2006. p53 suppresses the Nrf2-dependent transcription of antioxidant response genes. J Biol Chem 281: 39776-39784.
28. Fei P, Wang W, Kim S, Wang S, Burns TF, Sax JK, Buzzai M, Dicker DT, McKenna WG, Bernhard EJ, et al. 2004. Bnip3L is induced by p53 under hypoxia, and its knock-down promotes tumor growth. Cancer Cell 6: 597-609.
29. Feng Z, Levine AJ. 2010. The regulation of energy metabolism and the IGF-1/mTOR pathways by the p53 protein. Trends Cell Biol 20: 427-434.
30. Feng J, Tamaskovic R, Yang Z, Brazil DP, Merlo A, Hess D, Hemmings BA. 2004. Stabilization of Mdm2 via decreased ubiquitination is mediated by protein kinase B/Akt-dependent phosphorylation. J Biol Chem 279: 35510-35517.
31. Feng Z, Hu W, De Stanchina E, Teresky AK, Jin S, Lowe S, Levine AJ. 2007. The regulation of AMPK b1, TSC2, and PTEN expression by p53: Stress, cell and tissue specificity, and the role of these gene products in modulating the IGF-1-AKT-mTOR pathways. Cancer Res 67: 3043-3053.
32. Feng X, Liu X, Zhang W, Xiao W. 2011. p53 directly suppresses BNIP3 expression to protect against hypoxia-in-duced cell death. EMBO J 30: 3397-3415.
33. Fiordaliso F, Leri A, Cesselli D, Limana F, Safai B, Nadal-Ginard B, Anversa P, Kajstura J. 2001. Hyperglycemia activates p53 and p53-regulated genes leading to myocyte cell death. Diabetes 50: 2363-2375.
34. Fliss H, Gattinger D. 1996. Apoptosis in ischemic and re-perfused rat myocardium. Circ Res 79: 949-956.
35. Frisardi V, Solfrizzi V, Seripa D, Capurso C, Santamato A, Sancarlo D, Vendemiale G, Pilotto A, Panza F. 2010. Metabolic-cognitive syndrome: A cross-talk between meta-bolic syndrome and Alzheimer’s disease. Ageing Res Rev 9: 399-417.
36. Garufi A, D’Orazi G. 2014. High glucose dephosphorylates serine 46 and inhibits p53 apoptotic activity. J Exp Clin Cancer Res 33: 79.
37. Gaulton KJ, Willer CJ, Li Y, Scott LJ, Conneely KN, Jackson AU, Duren WL, Chines PS, Narisu N, Bonnycastle LL, et al. 2008. Comprehensive association study of type 2 dia-betes and related quantitative traits with 222 candidate genes. Diabetes 57: 3136-3144.
38. Goldstein I, Rotter V. 2012. Regulation of lipid metabolism by p53—Fighting two villains with one sword. Trends Endocrinol Metab 23: 567-575.
39. Goldstein I, Yizhak K, Madar S, Goldfinger N, Ruppin E, Rotter V. 2013. p53 promotes the expression of gluconeogenesis-related genes and enhances hepatic glucose production. Cancer Metab 1: 9.
40. Gomes LC, Di Benedetto G, Scorrano L. 2011. During autophagy mitochondria elongate, are spared from degradation and sustain cell viability. Nat Cell Biol 13: 589-598.
41. Guo K, Searfoss G, Krolikowski D, Pagnoni M, Franks C, Clark K, Yu KT, Jaye M, Ivashchenko Y. 2001. Hypoxia induces the expression of the pro-apoptotic gene BNIP3. Cell Death Differ 8: 367-376.
42. Hammond EM, Giaccia AJ. 2005. The role of p53 in hypoxia-induced apoptosis. Biochem Biophys Res Commun 331: 718-725.
43. Hammond EM, Giaccia AJ. 2006. Hypoxia-inducible factor-1 and p53: Friends, acquaintances, or strangers? Clin Cancer Res 12: 5007-5009.
44. Hammond EM, Denko NC, Dorie MJ, Abraham RT, Giaccia AJ. 2002. Hypoxia links ATR and p53 through replication arrest. Mol Cell Biol 22: 1834-1843.
45. Hardie DG. 2011. AMP-activated protein kinase-an energy sensor that regulates all aspects of cell function. Genes Dev 25: 1895-1908.
46. Hardie DG, Ross FA, Hawley SA. 2012. AMPK: A nutrient and energy sensor that maintains energy homeostasis. Nat Rev Mol Cell Biol 13: 251-262.
47. Hay N, Sonenberg N. 2004. Upstream and downstream of mTOR. Genes Dev 18: 1926-1945.
48. Horn HF, Vousden KH. 2007. Coping with stress: Multiple ways to activate p53. Oncogene 26: 1306-1316.
49. Hoshino A, Matoba S, Iwai-Kanai E, Nakamura H, Kimata M, Nakaoka M, Katamura M, Okawa Y, Ariyoshi M, Mita Y, et al. 2012. p53-TIGAR axis attenuates mitophagy to exacerbate cardiac damage after ischemia. J Mol Cell Cardiol 52: 175-184.
50. Hu W, Zhang C, Wu R, Sun Y, Levine A, Feng Z. 2010. Glutaminase 2, a novel p53 target gene regulating energy metabolism and antioxidant function. Proc Natl Acad Sci 107: 7455-7460.
51. Huang PL. 2009. A comprehensive definition for metabolic syndrome. Dis Model Mech 2: 231-237.
52. Imamura K, Ogura T, Kishimoto A, Kaminishi M, Esumi H. 2001. Cell cycle regulation via p53 phosphorylation by a 50-AMP activated protein kinase activator, 5-aminoimi-dazole-4-carboxamide-1-b-D-ribofuranoside, in a hu-man hepatocellular carcinoma cell line. Biochem Biophys Res Commun 287: 562-567.
53. Jaramillo M, Zhang D. 2013. The emerging role of the Nrf2-Keap1 signaling pathway in cancer. Genes Dev 27: 2179-2191.
54. Jiang P, Du W, Wang X, Mancuso A, Gao X, Wu M, Yang X. 2011. p53 regulates biosynthesis through direct inactivation of glucose-6-phosphate dehydrogenase. Nat Cell Biol 13: 310-316.
55. Jiang P, Du W, Mancuso A, Wellen KE, Yang X. 2013. Reciprocal regulation of p53 and malic enzymes modulates metabolism and senescence. Nature 493: 689-693.
56. Jiang D, LaGory EL, Kenzelmann Brož D, Bieging KT, Brady CA, Link N, Abrams JM, Giaccia AJ, Attardi LD. 2015. Analysis of p53 transactivation domain mutants reveals Acad11 as a metabolic target important for p53 prosurvival function. Cell Rep 10: 1096-1109.
57. Jones RG, Plas DR, Kubek S, Buzzai M, Mu J, Xu Y, Birn-baum MJ, Thompson CB. 2005. AMP-activated protein kinase induces a p53-dependent metabolic checkpoint. Mol Cell 18: 283-293.
58. Jung H, Kim MJ, Kim DO, Kim WS, Yoon SJ, Park YJ, Yoon SR, Kim TD, Suh HW, Yun S, et al. 2013. TXNIP maintains the hematopoietic cell pool by switching the func-tion of p53 under oxidative stress. Cell Metab 18: 75-85.
59. Kang MY, Kim H-B, Piao C, Lee KH, Hyun JW, Chang I-Y, You HJ. 2012. The critical role of catalase in prooxidant and antioxidant function of p53. Cell Death Differ 20: 117-129.
60. Kaur J. 2014. A comprehensive review on metabolic syn-drome. Cardiol Res Pract 2014: 943162.
61. Kawauchi K, Araki K, Tobiume K, Tanaka N. 2008. p53 regulates glucose metabolism through an IKK-NF-kB pathway and inhibits cell transformation. Nat Cell Biol 10: 611-618.
62. Kim JY, Ahn HJ, Ryu JH, Suk K, Park JH. 2004. BH3-only protein Noxa is a mediator of hypoxic cell death induced by hypoxia-inducible factor 1a. J Exp Med 199: 113-124.
63. Kimata M, Matoba S, Iwai-Kanai E, Nakamura H, Hoshino A, Nakaoka M, Katamura M, Okawa Y, Mita Y, Okigaki M, et al. 2010. p53 and TIGAR regulate cardiac myocyte energy homeostasis under hypoxic stress. Am J Physiol Heart Circ Physiol 299: H1908-H1916.
64. Kitamura N, Nakamura Y, Miyamoto Y, Miyamoto T, Kabu K, Yoshida M, Futamura M, Ichinose S, Arakawa H. 2011. Mieap, a p53-inducible protein, controls mitochondrial quality by repairing or eliminating unhealthy mitochondria. PLoS ONE 6: e16060.
65. Kondoh H, Lleonart ME, Gil J, Wang J, Degan P, Peters G, Martinez D, Carnero A, Beach D. 2005. Glycolytic enzymes can modulate cellular life span. Cancer Res 65: 177-185.
66. Koumenis C, Alarcon R, Hammond E, Sutphin P, Hoffman W, Murphy M, Derr J, Taya Y, Lowe SW, Kastan M, et al. 2001. Regulation of p53 by hypoxia: Dissociation of transcriptional repression and apoptosis from p53-dependent transactivation. Mol Cell Biol 21: 1297-1310.
67. Kurland IJ, Pilkis SJ. 1995. Covalent control of 6-phospho-fructo-2-kinase/fructose-2,6-bisphosphatase: Insights into autoregulation of a bifunctional enzyme. Protein Sci 4: 1023-1037.
68. Laplante M, Sabatini DM. 2012. MTOR signaling in growth control and disease. Cell 149: 274-293.
69. Lau ATY, Wang Y, Chiu JF. 2008. Reactive oxygen species: Current knowledge and applications in cancer research and therapeutic. J Cell Biochem 104: 657-667.
70. Le A, Lane AN, Hamaker M, Bose S, Gouw A, Barbi J, Tsukamoto T, Rojas CJ, Slusher BS, Zhang H, et al. 2012. Glucose-independent glutamine metabolism via TCA cycling for proliferation and survival in B cells. Cell Metab 15: 110-121.
71. Lee CH, Inoki K, Karbowniczek M, Petroulakis E, Sonenberg N, Henske EP, Guan KL. 2007. Constitutive mTOR activation in TSC mutants sensitizes cells to energy starvation and genomic damage via p53. EMBO J 26: 4812-4823.
72. Levine B, Kroemer G. 2008. Autophagy in the pathogenesis of disease. Cell 132: 27-42.
73. Li H, Jogl G. 2009. Structural and biochemical studies of TIGAR (TP53-induced glycolysis and apoptosis regulator). J Biol Chem 284: 1748-1754.
74. Li J, Zhang X, Sejas DP, Bagby GC, Pang Q. 2004. Hypoxia-induced nucleophosmin protects cell death through inhibition of p53. J Biol Chem 279: 41275-41279.
75. Liu Z, Lu H, Shi H, Du Y, Yu J, Gu S, Chen X, Ke JL, Hu CAA. 2005. PUMA overexpression induces reactive oxygen species generation and proteasome-mediated stathmin degradation in colorectal cancer cells. Cancer Res 65: 1647-1654.
76. Liu B, Chen Y, St Clair DK. 2008. ROS and p53: A versatile partnership. Free Radic Biol Med 44: 1529-1535.
77. Liu Y, He Y, Jin A, Tikunov AP, Zhou L, Tollini L, Leslie P, Kim TH, Li LO, Coleman R, et al. 2014. Ribosomal protein-Mdm2-p53 pathway coordinates nutrient stress with lipid metabolism by regulating MCD and promot-ing fatty acid oxidation. Proc Natl Acad Sci 111: E2414-E2422.
78. Maddocks ODK, Berkers CR, Mason SM, Zheng L, Blyth K, Gottlieb E, Vousden KH. 2013. Serine starvation induces stress and p53-dependent metabolic remodelling in cancer cells. Nature 493: 542-546.
79. Maiuri MC, Galluzzi L, Morselli E, Kepp O, Malik SA, Kroe-mer G. 2010. Autophagy regulation by p53. Curr Opin Cell Biol 22: 181-185.
80. Martin HL, Teismann P. 2009. Glutathione—A review on its role and significance in Parkinson’s disease. FASEB J 23: 3263-3272.
81. Mathupala SP, Heese C, Pedersen PL. 1997. Glucose catabolism in cancer cells. The type II hexokinase promoter contains functionally active response elements for the tumor suppressor p53. J Biol Chem 272: 22776-22780.
82. Mathupala SP, Ko YH, Pedersen PL. 2006. Hexokinase II: Cancer’s double-edged sword acting as both facilitator and gatekeeper of malignancy when bound to mitochondria. Oncogene 25: 4777-4786.
83. Matoba S, Kang JG, Patino WD, Wragg A, Boehm M, Gavrilova O, Hurley PJ, Bunz F, Hwang PM. 2006. p53 regulates mitochondrial respiration. Science 312: 1650-1653.
84. Matsusaka H, Ide T, Matsushima S, Ikeuchi M, Kubota T, Sunagawa K, Kinugawa S, Tsutsui H. 2006. Targeted deletion of p53 prevents cardiac rupture after myocardial infarction in mice. Cardiovasc Res 70: 457-465.
85. Mayo LD, Donner DB. 2001. A phosphatidylinositol 3-kinase/Akt pathway promotes translocation of Mdm2 from the cytoplasm to the nucleus. Proc Natl Acad Sci 98: 11598-11603.
86. Miceli AP, Saporita AJ, Weber JD. 2012. Hypergrowth mTORC1 signals translationally activate the ARF tumor suppressor checkpoint. Mol Cell Biol 32: 348-364.
87. Minamino T, Orimo M, Shimizu I, Kunieda T, Yokoyama M, Ito T, Nojima A, Nabetani A, Oike Y, Matsubara H, et al. 2009. A crucial role for adipose tissue p53 in the regula-tion of insulin resistance. Nat Med 15: 1082-1087.
88. Mor I, Cheung EC, Vousden KH. 2011. Control of glycolysis through regulation of PFK1: Old friends and recent additions. Cold Spring Harb Symp Quant Biol 76: 211-216.
89. Moremen KW, Tiemeyer M, Nairn AV. 2012. Vertebrate protein glycosylation: Diversity, synthesis and function. Nat Rev Mol Cell Biol 13: 448-462.
90. Morselli E, Galluzzi L, Kepp O, Vicencio JM, Criollo A, Maiuri MC, Kroemer G. 2009. Anti-and pro-tumor functions of autophagy. Biochim Biophys Acta Mol Cell Res 1793: 1524-1532.
91. Mungamuri SK, Yang X, Thor AD, Somasundaram K. 2006. Survival signaling by Notch1: Mammalian target of rapamycin (mTOR)-dependent inhibition of p53. Cancer Res 66: 4715-4724.
92. Ogawara Y, Kishishita S, Obata T, Isazawa Y, Suzuki T, Tanaka K, Masuyama N, Gotoh Y. 2002. Akt enhances Mdm2-mediated ubiquitination and degradation of p53. J Biol Chem 277: 21843-21850.
93. Okamura S, Ng CC, Koyama K, Takei Y, Arakawa H, Mon-den M, Nakamura Y. 1999. Identification of seven genes regulated by wild-type p53 in a colon cancer cell line carrying a well-controlled wild-type p53 expression sys-tem. Oncol Res 11: 281-285.
94. Okorokov AL, Milner J. 1999. An ATP/ADP-dependent molecular switch regulates the stability of p53-DNA complexes. Mol Cell Biol 19: 7501-7510.
95. Okoshi R, Ozaki T, Yamamoto H, Ando K, Koida N, Ono S, Koda T, Kamijo T, Nakagawara A, Kizaki H. 2008. Activation of AMP-activated protein kinase induces p53-de-pendent apoptotic cell death in response to energetic stress. J Biol Chem 283: 3979-3987.
96. Ou Y, Wang SJ, Jiang L, Zheng B, Gu W. 2015. p53 protein-mediated regulation of phosphoglycerate dehydrogenase (PHGDH) is crucial for the apoptotic response upon serine starvation. J Biol Chem 290: 457-466.
97. Pan Y, Oprysko PR, Asham AM, Koch CJ, Simon MC. 2004. p53 cannot be induced by hypoxia alone but responds to the hypoxic microenvironment. Oncogene 23: 4975-4983.
98. Peterson TR, Sengupta SS, Harris TE, Carmack AE, Kang SA, Balderas E, Guertin DA, Madden KL, Carpenter AE, Finck BN, et al. 2011. MTOR complex 1 regulates lipin 1 localization to control the SREBP pathway. Cell 146: 408-420.
99. Polyak K, Xia Y, Zweier JL, Kinzler KW, Vogelstein B. 1997. A model for p53-induced apoptosis. Nature 389: 300-305.
100. Rabinowitz JD, White E. 2010. Autophagy and metabolism. Science 330: 1344-1348.
101. Reid MA, Wang WI, Rosales KR, Welliver MX, Pan M, Kong M. 2013. The B55a subunit of PP2A drives a p53-dependent metabolic adaptation to glutamine deprivation. Mol Cell 50: 200-211.
102. Ruiz-Lozano P, Hixon ML, Wagner MW, Flores AI, Ikawa S, Baldwin AS, Chien KR, Gualberto A. 1999. p53 is a transcriptional activator of the muscle-specific phosphoglyc-erate mutase gene and contributes in vivo to the control of its cardiac expression. Cell Growth Differ 10: 295-306.
103. Sablina AA, Budanov AV, Ilyinskaya GV, Agapova LS, Kravchenko JE, Chumakov PM. 2005. The antioxidant function of the p53 tumor suppressor. Nat Med 11: 1306-1313.
104. Sahin E, Colla S, Liesa M, Moslehi J, Muller FL, Guo M, Cooper M, Kotton D, Fabian AJ, Walkey C, et al. 2011. Telomere dysfunction induces metabolic and mitochondrial compromise. Nature 470: 359-365.
105. Santos CR, Schulze A. 2012. Lipid metabolism in cancer. FEBS J 279: 2610-2623.
106. Saqcena M, Mukhopadhyay S, Hosny C, Alhamed A, Chat-terjee A, Foster D. 2014. Blocking anaplerotic entry of glutamine into the TCA cycle sensitizes K-Ras mutant cancer cells to cytotoxic drugs. Oncogene 34: 1-9.
107. Scherz-Shouval R, Weidberg H, Gonen C, Wilder S, Elazar Z, Oren M. 2010. p53-dependent regulation of autoph-agy protein LC3 supports cancer cell survival under pro-longed starvation. Proc Natl Acad Sci 107: 18511-18516.
108. Schleicher ED, Weigert C. 2000. Role of the hexosamine biosynthetic pathway in diabetic nephropathy. Kidney Int Suppl 77: S13-S18.
109. Schmid T, Zhou J, Brune B. 2004. HIF-1 and p53: Commu-nication of transcription factors under hypoxia. J Cell Mol Med 8: 423-431.
110. Schwartzenberg-baryoseph F, Armoni M, Karnieli E. 2004. The tumor suppressor p53 down-regulates glucose transporters GLUT1 and GLUT4 gene expression. Cancer Res 64: 2627-2633.
111. Sen N, Satija YK, Das S. 2011. PGC-1a, a key modulator of p53, promotes cell survival upon metabolic stress. Mol Cell 44: 621-634.
112. Sena LA, Chandel NS. 2012. Physiological roles of mito-chondrial reactive oxygen species. Mol Cell 48: 158-167.
113. Sermeus A, Michiels C. 2011. Reciprocal influence of the p53 and the hypoxic pathways. Cell Death Dis 2: e164.
114. Shizukuda Y, Matoba S, Mian OY, Nguyen T, Hwang PM. 2005. Targeted disruption of p53 attenuates doxorubicin-induced cardiac toxicity in mice. Mol Cell Biochem 273: 25-32.
115. Sinthupibulyakit C, Ittarat W, St Clair WH, St Clair DK. 2010. p53 protects lung cancer cells against metabolic stress. Int J Oncol 37: 1575-1581.
116. Son J, Lyssiotis C, Ying H, Wang X, Hua S, Ligorio M, Perera RM, Ferrone CR, Mullarky E, Shyh-Chang N, et al. 2013. Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway. Nature 496: 101-105.
117. Sowter HM, Ratcliffe PJ, Watson P, Greenberg AH, Harris AL. 2001. HIF-1-dependent regulation of hypoxic induction of the cell death factors BNIP3 and NIX in human tumors. Cancer Res 61: 6669-6673.
118. Stambolsky P, Weisz L, Shats I, Klein Y, Goldfinger N, Oren M, Rotter V. 2006. Regulation of AIF expression by p53. Cell Death Differ 13: 2140-2149.
119. Subbaramaiah K, Michaluart P, Chung WJ, Tanabe T, Telang N, Dannenberg AJ. 1999. Resveratrol inhibits cyclooxygenase-2 transcription in human mammary epithelial cells. Ann NY Acad Sci 889: 214-223.
120. Suzuki S, Tanaka T, Poyurovsky MV, Nagano H, Mayama T, Ohkubo S, Lokshin M, Hosokawa H, Nakayama T, Suzuki Y, et al. 2010. Phosphate-activated glutaminase (GLS2), a p53-inducible regulator of glutamine metabo-lism and reactive oxygen species. Proc Natl Acad Sci 107: 7461-7466.
121. Tan M, Li S, Swaroop M, Guan K, Oberley LW, Sun Y. 1999. Transcriptional activation of the human glutathione peroxidase promoter by p53. J Biol Chem 274: 12061-12066.
122. Tasdemir E, Maiuri MC, Galluzzi L, Vitale I, Djavaheri-Mergny M, D’Amelio M, Criollo A, Morselli E, Zhu C, Harper F, et al. 2008. Regulation of autophagy by cyto-plasmic p53. Nat Cell Biol 10: 676-687.
123. Tu HC, Ren D, Wang GX, Chen DY, Westergard TD, Kim H, Sasagawa S, Hsieh JJD, Cheng EHY. 2009. The p53 cathepsin axis cooperates with ROS to activate pro-grammed necrotic death upon DNA damage. Proc Natl Acad Sci 106: 1093-1098.
124. Vahsen N, Candé C, Brière JJ, Bénit P, Joza N, Larochette N, Mastroberardino PG, Pequignot MO, Casares N, Lazar V, et al. 2004. AIF deficiency compromises oxidative phos-phorylation. EMBO J 23: 4679-4689.
125. Vander Heiden MG, Cantley LC, Thompson CB. 2009. Understanding the Warburg effect: The metabolic requirements of cell proliferation. Science 324: 1029-1033.
126. Vazquez A, Oltvai ZN. 2011. Molecular crowding defines a common origin for the Warburg effect in proliferating cells and the lactate threshold in muscle physiology. PLoS ONE 6: 9.
127. Vazquez A, Markert EK, Oltvai ZN. 2011. Serine biosyn-thesis with one carbon catabolism and the glycine cleavage system represents a novel pathway for ATP generation. PLoS ONE 6: 10.
128. Villeneuve NF, Sun Z, Chen W, Zhang DD. 2009. Nrf2 and p21 regulate the fine balance between life and death by controlling ROS levels. Cell Cycle 8: 3255-3256.
129. Voet D, Voet J. 2011. Biochemistry. Wiley, New York.
130. Vogelstein B, Lane D, Levine J. 2000. Surfing the p53 network. Nature 408: 307-310.
131. Vousden KH, Prives C. 2009. Blinded by the light: The growing complexity of p53. Cell 137: 413-431.
132. Vousden KH, Ryan KM. 2009. p53 and metabolism. Nat Rev Cancer 9: 691-700.
133. Wang J, Bin Erickson JW, Fuji R, Ramachandran S, Gao P, Dinavahi R, Wilson KF, Ambrosio ALB, Dias SMG, Dang CV, et al. 2010. Targeting mitochondrial glutaminase activity inhibits oncogenic transformation. Cancer Cell 18: 207-219.
134. Wang EY, Gang H, Aviv Y, Dhingra R, Margulets V, Kirshen-baum A, Kirshenbaum LA. 2013. p53 mediates autophagy and cell death by a mechanism contingent on Bnip3. Hypertension 62: 70-77.
135. Warburg O. 1956. On the origin of cancer cells. Science 123: 309-314.
136. Weidemann A, Johnson RS. 2008. Biology of HIF-1a. Cell Death Differ 15: 621-627.
137. Weinberg R. 2007. The biology of cancer. Garland Science, New York.
138. Wek RC, Jiang HY, Anthony TG. 2006. Coping with stress: eIF2 kinases and translational control. Biochem Soc Trans 34: 7-11.
139. Wellen KE, Thompson CB. 2010. Cellular metabolic stress: Considering how cells respond to nutrient excess. Mol Cell 40: 323-332.
140. White E. 2012. Deconvoluting the context-dependent role for autophagy in cancer. Nat Rev Cancer 12: 401-410.
141. White E. 2016. Autophagy and p53. Cold Spring Harb Perspect Med doi: 10.1101/cshperspect.a026120.
142. Yahagi N, Shimano H, Matsuzaka T, Najima Y, Sekiya M, Nakagawa Y, Ide T, Tomita S, Okazaki H, Tamura Y, et al. 2003. p53 activation in adipocytes of obese mice. J Biol Chem 278: 25395-25400.
143. Yellon DM, Hausenloy DJ. 2007. Myocardial reperfusion injury. N Engl J Med 357: 1121-1135.
144. Yoon K, Nakamura Y, Arakawa H. 2004. Identification of ALDH4 as a p53-inducible gene and its protective role in cellular stresses. J Hum Genet 49: 134-140.
145. Zaugg K, Yao Y, Reilly PT, Kannan K, Kiarash R, Mason J, Huang P, Sawyer SK, Fuerth B, Faubert B, et al. 2011. Carnitine palmitoyltransferase 1C promotes cell survival and tumor growth under conditions of metabolic stress. Genes Dev 25: 1041-1051.
146. Zhang J, Ney PA. 2009. Role of BNIP3 and NIX in cell death, autophagy, and mitophagy. Cell Death Differ 16: 939-946.
147. Zoncu R, Efeyan A, Sabatini DM. 2011a. mTOR: From growth signal integration to cancer, diabetes and ageing. Nat Rev Mol Cell Biol 12: 21-35.
148. Zoncu R, Bar-Peled L, Efeyan A, Wang S, Sancak Y, Sabatini DM. 2011b. mTORC1 senses lysosomal amino acids through an inside-out mechanism that requires the vacuolar Hþ-ATPase. Science 334: 678-683.